Downloadable PDF By Adam J. Fein, Ph.D.
HIN's Ninth Annual Industry Forecast-Get Your Copy Today!
Healthcare Trends & Forecasts in 2014: Performance Expectations for the Healthcare Industry, HIN's ninth annual industry forecast, provides both a handle on what's keeping healthcare CEOs up at night and a dream prescription for sounder program management in 2014. (Source: Healthcare Intelligence Network, December, 2013).
Available for purchase now.
This Healthcare Intelligence Network (HIN) report, Guide to Value-Based Reimbursement: Profiting from Payment Bundling, PHO Shared Savings, and Pay for Performance, explores emerging models of episode-based payments, physician-hospital organizations and physician bonus structures.
Purchase your copy here.
This report provides pharmaceutical and biotech organizations an opportunity to benchmark their own Health Economics and Outcomes Research (HEOR) approaches against that of Top 50 Pharma companies. Download Report Preview here. (Source: ISR reports, 2013).
For anyone who wants to understand and benefit from the forces reshaping the highly competitive U.S. pharmacy industry, the 2012
The Real World Data Report is a crucial up-to-date, independent and strategic insight into the most cutting edge
real world data practices. The report extract, with contributions from GSK, NovoNordisk, Pfizer, Sanofi, Janssen,
BMS and Amgen as well the AHRQ shares data sources they use and how they deal with issues such as data gaps, non-
standardization and retrospective study data.
Pricing pressure and regulatory restrictions across various healthcare industries have called for more detailed
evidence of outcomes of healthcare products. In order to gain market access, medical technology manufacturers
must be able to demonstrate the clinical and economic evidence to providers, healthcare decision-makers and
payers to be able to remain competitive.